General
Preferred name
GLYCINE
Synonyms
2-Aminoacetic Acid ()
Glycolixir ()
Aminoacetic acid ()
Glycosthene ()
Glycocoll ()
magnesium 2-aminoacetate ()
Magnesium diglycinate ()
ALUMINIUM TRIGLYCINATE ()
Dihydroxyaluminium ()
Magnesium glycinate ()
2-Aminoacetic acid, Aminoacetic acid, Glycocoll ()
[14C]glycine ()
FEMA NO. 3287 ()
NSC-25936 ()
Glicina ()
ALUMINIUM GLYCINATE ()
Glycine-13C ()
Glycine-d5 ()
Zinc glycinate ()
Zinc glycinate citrate ()
P&D ID
PD010204
CAS
52729-29-0
56-40-6
25718-94-9
52955-63-2
18875-39-3
13682-92-3
14783-68-7
14281-83-5
20220-62-6
4896-77-9
Tags
available
drug
endogenous
drug candidate
Approved by
FDA
First approval
1976
1982
Drug indication
Malnutrition
Skin inflammation
Hypertension
Drug Status
vet_approved
approved
investigational
nutraceutical
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
PRICE 29
DESCRIPTION Glycine is an amino acid commonly used as a component of total parenteral nutrition and is also used as irrigation during surgery. Glycine is a subunit specific modulator of the N-methyl-D-aspartate (NMDA) receptor. (Enamine Bioactive Compounds)
DESCRIPTION Kainate agonist; excitant and neurotoxin (Tocris Bioactive Compound Library)
DESCRIPTION glycine (2-Aminoacetic acid) is a non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. (TargetMol Bioactive Compound Library)
DESCRIPTION Magnesium glycinate (magnesium 2-aminoacetate) is a supplement that boost magnesium levels in people with a deficiency of the mineral. Magnesium is a vital nutrient for regulating many body processes, including muscle and nerve function, blood sugar levels, and blood pressure. This mineral also supports the making of protein, bone, and DNA. (TargetMol Bioactive Compound Library)
Compound Sets
26
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
Ki Database
NCATS Inxight Approved Drugs
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
231
Properties
(calculated by RDKit )
Molecular Weight
75.03
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
1
Ring Count
0
Aromatic Ring Count
0
cLogP
-0.97
TPSA
63.32
Fraction CSP3
0.5
Chiral centers
0.0
Largest ring
0.0
QED
0.42
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Metabolism
Neuroscience
Primary Target
NMDA Receptors
MOA
Endogenous Metabolite
iGluR
Modulator
glutamate receptor antagonist
Target
AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9
MT1 receptor
MT2 receptor
Therapeutic Class
Antiinflammatory Agents
Dietary supplement
Source data